Patient protection

September 2007
Industrial Laser Solutions;Sep2007, Vol. 22 Issue 9, p4
The article reports on the dangers of drug prescription counterfeiting in the U.S. According to John Cox, senior advisor of the Roberts Group, prescription drug counterfeiting is a threat to the health and safety of citizens. The size of the problem cannot be accurately measured, but it is estimated that drug counterfeiting has the potential to become a $75 billion industry by 2010.


Related Articles

  • EU anti-counterfeiting legislation on its way. Menardo, Frederic; Smith, Graham // Pharmaceutical Technology Europe;Jul2010, Vol. 22 Issue 7, p18 

    The article focuses on the amendment of the current anti-counterfeiting directive from the European Parliament in Europe. The legislation contains a stricter rule which requires the identification, authentication, and traceability of prescription medicines. This process can be attained by...

  • Making sense of the new acronyms. Posey, L. Michael // Pharmacy Today;Sep2010, Vol. 16 Issue 9, p6 

    An introduction to the journal is presented in which the editor discusses an article on the view on community-versus-hospital separation and the on the health care reform by L. David Harrow III, large-scale thefts in pharmaceutical, and counterfeiting in pharmaceutical.

  • Fighting Back.  // Pharmaceutical Technology Europe;Nov2011, Vol. 23 Issue 11, p24 

    The article reports that pharmaceutical companies are encountering the issue of falsified medicine and they are implementing various strategies to deal with medicine counterfeiting which includes code verification and inspection systems.

  • Substandard drugs overshadowed by focus on fakes. Katsnelson, Alla // Nature Medicine;Apr2010, Vol. 16 Issue 4, p364 

    The article focuses on the substandard pharmaceutical markets of India where medicines are made and marketed by illegitimate drug companies that contain compromised levels of active ingredients.

  • Battle against counterfeit medications intensifies.  // Chain Drug Review;1/6/2014, Vol. 36 Issue 1, p97 

    The article reports on the collaborations among pharmaceutical firms and patient safety organizations in the U.S. and abroad to fight the growth of counterfeit medications.

  • 2002 Rx MARKET: A LOOK IN THE REARVIEW MIRROR. Gebhart, Fred // Drug Topics;3/17/2003, Vol. 147 Issue 6, p37 

    Provides an overview on the prescription drug market in the United States in 2002. Percentage decline in prescription orders; Increase in prescription refills; Popular prescription drugs; Growth in generic drug sales.

  • Prescribing update. Saunders, Carol S.; Krohn, Talia S. // Patient Care;8/30/2000, Vol. 34 Issue 16, p9 

    Presents news updates pertaining to drug prescribing in the United States as of August 30, 2000. Novo Nordisk AS' insulin aspart injection NovoLog; Immunex Corp.'s Enbrel etanercept; Briston-Myers Squibb Co.'s Pravachol pravastatin.

  • Tainted Intentions from the Health Care Industry.  // Nutrition Health Review: The Consumer's Medical Journal;2002, Issue 84, p19 

    Reports on the economic growth of pharmaceutical companies in the U.S. Profits from prescription drug advertising; Benefits provided by pharmaceutical companies to physicians for drug prescription; Need to reform drug prescription system.

  • What Does Pharmacy Automation Mean for Packaging? Forcinio, Hallie // Pharmaceutical Technology North America;Jan2002, Vol. 26 Issue 1, p22 

    Focuses on the impact of automated pharmacy prescriptions to the packaging demand of drug manufacturers in the U.S. Security measures of the packaging process; Growth number of prescriptions for solid dosage forms; Quality assurance of the packaging process.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics